Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
Roundtable: How can pharma close the gender health gap?
Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.
Read more
Dr Andreas Konieczny on leading with authenticity
Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.
Pharma in Ireland
The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.
The curious paradox in cardiovascular disease
To mark World Heart Day 2023, how can the industry strike a balance between driving innovation and ensuring access to care for all?
How to satisfy the curious key opinion leader
How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to involved?
Should sales be a ‘dirty’ word in medical affairs?
Medical affairs and sales teams have distinctly different roles, but aren’t they just two planets orbiting the same sun?
Catching the ever elusive insight
How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?
Staying out of hot water on social media
As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?
Going for gold in gynaecological cancers
The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?
Loading posts...
« Previous
1
2
3
4
…
29
Next »